We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$4.34B
Cap. Flow %
18.68%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Consumer Discretionary 11.26%
3 Healthcare 10.95%
4 Financials 10.85%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VICR icon
751
Vicor
VICR
$8.33B
$3.75M 0.02%
79,944
+70,373
+735% +$3.9M
DIOD icon
752
Diodes
DIOD
$3.5B
$3.75M 0.02%
40,412
+30,915
+326% +$2.77M
PRVB
753
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$3.72M 0.02%
154,314
+52,943
+52% +$664K
ASAI
754
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$3.71M 0.02%
241,116
+155,472
+182% +$2.75M
REGN icon
755
Regeneron Pharmaceuticals
REGN
$72.9B
$3.71M 0.02%
4,519
-102,160
-96% -$77.1M
DNB
756
DELISTED
Dun & Bradstreet
DNB
$3.71M 0.02%
315,690
-832,415
-73% -$10.6M
OIH icon
757
VanEck Oil Services ETF
OIH
$1.97B
$3.7M 0.02%
13,360
+11,860
+791% +$3.63M
SYNA icon
758
Synaptics
SYNA
$4.05B
$3.66M 0.02%
32,886
+2,470
+8% +$285K
PG icon
759
Procter & Gamble
PG
$340B
$3.64M 0.02%
+24,470
New +$3.5M
ATSG
760
DELISTED
Air Transport Services Group
ATSG
$3.63M 0.02%
174,366
+28,764
+20% +$695K
BOOT icon
761
Boot Barn
BOOT
$4.58B
$3.63M 0.02%
47,380
+42,233
+821% +$3.24M
WABC icon
762
Westamerica Bancorp
WABC
$1.39B
$3.63M 0.02%
81,830
+47,155
+136% +$2.54M
RYZ
763
Ryerson Holding Corp
RYZ
$1.49B
$3.62M 0.02%
99,431
+50,696
+104% +$1.84M
TNL icon
764
Travel + Leisure Co
TNL
$4.76B
$3.62M 0.02%
92,232
-346,772
-79% -$14M
CYTK icon
765
Cytokinetics
CYTK
$10.6B
$3.61M 0.02%
+102,498
New +$4.18M
BVN icon
766
Compañía de Minas Buenaventura
BVN
$7.68B
$3.61M 0.02%
440,750
-59,071
-12% -$471K
ARCO icon
767
Arcos Dorados Holdings
ARCO
$1.74B
$3.59M 0.02%
466,241
+71,292
+18% +$586K
SKY icon
768
Champion Homes
SKY
$4.41B
$3.57M 0.02%
47,512
-11,344
-19% -$732K
KBAL
769
DELISTED
Kimball International
KBAL
$3.57M 0.02%
287,728
+267,427
+1,317% +$2.3M
AGCO icon
770
AGCO
AGCO
$8.41B
$3.56M 0.02%
+26,320
New +$3.56M
APLE icon
771
Apple Hospitality REIT
APLE
$3.97B
$3.54M 0.02%
228,060
+70,004
+44% +$1.15M
HLMN icon
772
Hillman Solutions
HLMN
$1.57B
$3.52M 0.02%
417,841
+184,571
+79% +$1.61M
BEAM icon
773
Beam Therapeutics
BEAM
$2.68B
$3.51M 0.02%
+114,568
New +$4.52M
BCC icon
774
Boise Cascade
BCC
$2.73B
$3.51M 0.02%
55,442
+15,111
+37% +$1.05M
CSGS
775
DELISTED
CSG Systems International
CSGS
$3.5M 0.02%
65,252
+15,140
+30% +$861K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.